4 transcripts
AORT
Earnings call transcript
NYSE
2024 Q2
8 Aug 24
currency basis. In the second quarter, we also continued to benefit from our regulatory approvals and commercial footprint expansion in key
AORT
Earnings call transcript
NYSE
2024 Q1
6 May 24
. In the first quarter, we also continued to benefit from our footprint expansion through regulatory approvals in key international markets. As a whole, our
AORT
Earnings call transcript
NYSE
2023 Q4
15 Feb 24
, each when compared to the fourth quarter of 2022, all on a constant currency basis. We've also benefited from the expansion of our commercial footprint
AORT
Earnings call transcript
NYSE
2023 Q2
3 Aug 23
business development expenses and benefits and other nonrecurring charges, G&A expenses were $45.9 million for the second quarter of 2023 compared to $41.8
- Prev
- 1
- Next